Tracing the Origin of Medicinal Substances
The origin of medicinal substances containing ethylene glycol and diethylene glycol should be traced. The two chemicals are suspected of triggering atypical progressive acute kidney injury in children.
/https%3A%2F%2Fasset.kgnewsroom.com%2Fphoto%2Fpre%2F2022%2F10%2F27%2F3e54b3f6-32af-4019-8c2b-e4641d2b5565_jpg.jpg){kind=logo}
Head of the Food and Drug Supervisory Agency (BPOM) Penny K Lukito (center, white mask) answers a reporter's question about drugs containing ethylene glycol and diethylene glycol contamination in Jakarta on Thursday (27/10/2022).
JAKARTA, KOMPAS— It is urgent to trace the origin of medicinal substances containing ethylene glycol and diethylene glycol contaminants. This is meant to reduce any future new cases of atypical progressive acute kidney injury in children.
The Food and Drug Authority (BPOM) Chief Penny K Lukito at a press conference in Jakarta on Thursday (27/10/2022) said two pharmaceutical industries were subjected to legal action by the National Police Criminal Investigation Agency. The medicines produced by both industries contain very high concentrations of ethylene glycol (EG) and diethylene glycol (DEG). EG and DEG are not allowed to be used for syrup drug production.